Prelica CR 165 mg is a controlled-release formulation of Pregabalin, containing 165 milligrams of the active ingredient per tablet. It is used for the management of neuropathic pain, fibromyalgia, generalized anxiety disorder, and as an adjunct treatment for partial-onset seizures. The "CR" (Controlled Release) formulation is designed to release the medication slowly over time, allowing for sustained therapeutic levels in the bloodstream and reduced dosing frequency—typically once daily. Pregabalin works by binding to calcium channels in the central nervous system, decreasing the release of certain neurotransmitters involved in pain and seizure transmission. Prelica CR 165 mg provides effective symptom control with a potentially lower risk of side effects such as dizziness and sedation due to its gradual absorption. This medication should only be taken under medical supervision, especially in patients with kidney issues or a history of drug dependence.